Table: Pharmarise Holdings -2020/21 group results

Pharmarise Holdings

15/07/2021 10:20

Jul 15 (Reuters)- 
          Pharmarise Holdings Corp 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2021    May 31, 2020   May 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             52.32           51.03          53.24        26.14    
                 (+2.5 pct)      (-1.3 pct)     (+1.7 pct)    (+1.8 pct) 
  Operating          1.25            1.03           1.50       690 mln   
                 (+20.4 pct)     (+61.6 pct)    (+20.7 pct)  (+31.4 pct) 
  Recurring          1.29            1.02           1.44       659 mln   
                 (+25.9 pct)     (+73.3 pct)    (+12.1 pct)  (+22.9 pct) 
  Net
  Net              426 mln         577 mln        438 mln      166 mln   
                 (-26.2 pct)                    (+2.8 pct)   (+30.2 pct) 
  EPS             45.83 yen       61.11 yen      47.19 yen    17.88 yen  
  EPS Diluted     34.64 yen       46.38 yen                              
  Ann Div         14.00 yen       14.00 yen      14.00 yen               
  -Q2 Div            NIL             NIL            NIL                  
  -Q4 Div         14.00 yen       14.00 yen      14.00 yen               
  
  NOTE - Pharmarise Holdings Corp.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T